Provided by Tiger Trade Technology Pte. Ltd.

Compass Therapeutics, Inc.

5.19
0.0000
Post-market: 5.10-0.0900-1.73%19:31 EDT
Volume:1.06M
Turnover:5.47M
Market Cap:934.66M
PE:-12.31
High:5.36
Open:5.27
Low:5.07
Close:5.19
52wk High:6.88
52wk Low:1.33
Shares:180.09M
Float Shares:119.00M
Volume Ratio:0.59
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4216
EPS(LYR):-0.4216
ROE:-41.29%
ROA:-25.29%
PB:4.75
PE(LYR):-12.31

Loading ...

Compass Therapeutics Reports Pipeline Progress and $209 Million Cash Runway Into 2028

Reuters
·
Jan 06

Compass Therapeutics: Initiation of Phase 2 Trial of Ctx-471 in Patients With Tumors Expressing Ncam (Cd56) Expected H1 2026

THOMSON REUTERS
·
Jan 06

Compass Therapeutics Inc. - Pfs and Os Analyses for Tovecimig in BTC on Track for Q1 2026

THOMSON REUTERS
·
Jan 06

Compass Therapeutics Inc. - Phase 1 Study of Ctx-10726 Expected to Start in Q1 2026, Initial Data Expected H2 2026

THOMSON REUTERS
·
Jan 06

Compass Therapeutics Provides Corporate Update

GlobeNewswire
·
Jan 06

Compass Therapeutics Files Initial Beneficial Ownership Statement for Chief Medical Officer Cynthia Sirard

Reuters
·
Jan 06

BRIEF-Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jan 06

Compass Therapeutics Grants Stock Options to New Employees Under 2025 Inducement Plan

Reuters
·
Jan 06

Compass Therapeutics' Bile Duct Cancer Drug Seen As New Standard Of Care

Benzinga
·
Jan 06

Compass Therapeutics Initiated at Outperform by William Blair

Dow Jones
·
Jan 05

Compass Therapeutics Appoints Arjun Prasad as Chief Commercial Officer and Cynthia Sirard as Chief Medical Officer

Reuters
·
Jan 05

Press Release: Compass Therapeutics Announces Key Leadership Appointments

Dow Jones
·
Jan 05

William Blair Initiates Compass Therapeutics at Outperform

MT Newswires Live
·
Jan 05

BRIEF-Compass Therapeutics Files For Up To $400 Million Mixed Shelf Offering- SEC Filing

Reuters
·
Dec 31, 2025

Compass Therapeutics Files $400 Million Mixed Shelf

MT Newswires Live
·
Dec 31, 2025

Compass Therapeutics Inc - Files for up to $400 Mln Mixed Shelf Offering- SEC Filing

THOMSON REUTERS
·
Dec 31, 2025

Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference

GlobeNewswire
·
Dec 17, 2025

Compass Therapeutics Initiated at Buy by Canaccord Genuity

Dow Jones
·
Dec 03, 2025

Cantor Fitzgerald Initiates Compass Therapeutics at Overweight

MT Newswires Live
·
Dec 03, 2025

Compass Therapeutics Inc. : Leerink Partners Raises Target Price to $11 From $7

THOMSON REUTERS
·
Nov 26, 2025